Skip to main content
Caplight Logo









Kiyatec

Kiyatec

Private
Greenville, South CarolinaHealthcare & Life Scienceshttps://kiyatec.com/

Last Round

Strategic

Nov 13, 2025

Total Funding Raised

$31.73M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Kiyatec is a functional precision oncology company that provides clinical testing and preclinical drug development services using proprietary 3D cell culture technology to predict patient-specific responses to cancer therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

3D cell cultureprecision oncologyex vivo testingtumor profilingcontract research organizationCROdrug development servicespatient-derived tumor modelsfunctional drug testingorganoid technologypreclinical researchclinical trial supportdrug response predictionlab servicesbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kiyatec Comparables

Compare Kiyatec with similar companies based on industry and business-model similarity.

Kiyatec comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Spanios
84%
Certis Oncology Solutions
82%
Invitrocue
81%

Kiyatec Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicNov 13, 2025
StrategicMay 18, 2023
Series CDec 12, 2022
Corporate FundingDec 14, 2021
VC RoundApr 30, 2021
VC Round
Jan 8, 2020

Kiyatec Investors

Notable investors and investment history

Kiyatec investors
InvestorRounds
National Institute of Biomedical Imaging and BioengineeringGrant
National Cancer InstituteGrant
The Sontag FoundationStrategic
Seae VenturesSeries C, VC Round
EsperanteVC Round
SC LaunchSeries A, VC Round
VentureSouthSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 13, 2025

    Completed a strategic funding round.

  • Dec 12, 2022

    $18M round led by Bruker.

Kiyatec Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kiyatec Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kiyatec's valuation, stock price, and market status.

Firmographic Details

HeadquartersGreenville, South Carolina
Employee Range14
Year Founded2005
Last FundingNov 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?